Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Two Postoperative Care Strategies After Breast Surgery
Sponsor: Moumtzidou Maria Aikaterini
Summary
The goal of this clinical trial is to compare two postoperative analgesia strategies in adult women undergoing breast surgery and to evaluate their effects on postoperative pain and quality of recovery after hospital discharge. The main questions it aims to answer are: * Does a patient education-based analgesia strategy improve postoperative pain control compared with standard analgesic management? * Does the patient education-based strategy improve quality of recovery after hospital discharge? Researchers will compare the patient education group with the standard care group to assess differences in postoperative pain intensity and quality of recovery. Participants will: * Receive either a patient education-based postoperative analgesia strategy or standard postoperative analgesic management. * Complete questionnaires assessing pain, quality of recovery, and other aspects of health at specified time points. * Be followed for 90 days after surgery.
Official title: The Impact of Patient Education on Postoperative Analgesia Strategy and Its Effect on Pain Intensity and Quality of Recovery After Hospital Discharge: A Pilot Prospective Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
108
Start Date
2026-10
Completion Date
2027-11
Last Updated
2026-10-19
Healthy Volunteers
No
Interventions
Patient Education
Structured patient education regarding postoperative pain management, including discussion of the analgesic strategy and appropriate use of pharmacological and non-pharmacological pain management measures.
Paracetamol
Paracetamol 1 g orally three times daily (3 g/day)
Dexketoprofen
Dexketoprofen 50 mg is administered intravenously every 12 hours during the first 48 hours postoperatively. It is then switched to oral dexketoprofen 25 mg every 12 hours for 3 days, followed by use as needed for pain until 7-14 days after surgery.
Pregabalin
Pregabalin 25-75 mg is administered orally every 12 hours for 30 days as part of the multimodal postoperative analgesic regimen
Tramadol
Tramadol 50-100 mg IV postoperatively as rescue therapy (maximum dose 300 mg/day). If the patient received tramadol during the postoperative period, oral tramadol 50 mg was continued as needed for pain for 4-7 days (maximum daily dose 300 mg)
Locations (1)
University General Hospital of Heraklion (PAGNI)
Heraklion, Crete, Greece